Clinical Trial Update: Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the immunogenicity and safety of primary and booster vaccination with GlaxoSmithKline's DTPa-HBV-IPV/Hib hexavalent vaccine. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pediarix (DTaP-HepB-IPV combination vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED